Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Ferguson

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
International Journal of Cancer|May 29, 2023
A phase II trial of nifurtimox combined with topotecan and cyclophosphamide for refractory or relapsed neuroblastoma and medulloblastomaDon Eslin, Peter E Zage, Genevieve Bergendahl, et al.
Cancer Medicine|February 28, 2015
Feasibility of implementing molecular-guided therapy for the treatment of patients with relapsed or refractory neuroblastomaGiselle L Saulnier Sholler, Jeffrey P Bond, Genevieve Bergendahl, et al.
Scientific Reports|September 29, 2018
Maintenance DFMO Increases Survival in High Risk NeuroblastomaGiselle L Saulnier Sholler, William Ferguson, Genevieve Bergendahl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2005
Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexatePaul A Meyers, Cindy L Schwartz, Mark Krailo, et al.
Plos One|May 29, 2015
A Phase I Trial of DFMO Targeting Polyamine Addiction in Patients with Relapsed/Refractory NeuroblastomaGiselle L Saulnier Sholler, Eugene W Gerner, Genevieve Bergendahl, et al.
Cancer Reports (Hoboken, N.J.)|March 31, 2022
A pilot study of genomic-guided induction therapy followed by immunotherapy with difluoromethylornithine maintenance for high-risk neuroblastomaJacqueline M Kraveka, Elizabeth C Lewis, Genevieve Bergendahl, et al.
Genome Medicine|February 12, 2024
Molecular-guided therapy for the treatment of patients with relapsed and refractory childhood cancers: a Beat Childhood Cancer Research Consortium trialGiselle L Saulnier Sholler, Genevieve Bergendahl, Elizabeth C Lewis, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
International Journal of Cancer|May 29, 2023
A phase II trial of nifurtimox combined with topotecan and cyclophosphamide for refractory or relapsed neuroblastoma and medulloblastomaDon Eslin, Peter E Zage, Genevieve Bergendahl, et al.
Cancer Medicine|February 28, 2015
Feasibility of implementing molecular-guided therapy for the treatment of patients with relapsed or refractory neuroblastomaGiselle L Saulnier Sholler, Jeffrey P Bond, Genevieve Bergendahl, et al.
Scientific Reports|September 29, 2018
Maintenance DFMO Increases Survival in High Risk NeuroblastomaGiselle L Saulnier Sholler, William Ferguson, Genevieve Bergendahl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2005
Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexatePaul A Meyers, Cindy L Schwartz, Mark Krailo, et al.
Plos One|May 29, 2015
A Phase I Trial of DFMO Targeting Polyamine Addiction in Patients with Relapsed/Refractory NeuroblastomaGiselle L Saulnier Sholler, Eugene W Gerner, Genevieve Bergendahl, et al.
Cancer Reports (Hoboken, N.J.)|March 31, 2022
A pilot study of genomic-guided induction therapy followed by immunotherapy with difluoromethylornithine maintenance for high-risk neuroblastomaJacqueline M Kraveka, Elizabeth C Lewis, Genevieve Bergendahl, et al.
Genome Medicine|February 12, 2024
Molecular-guided therapy for the treatment of patients with relapsed and refractory childhood cancers: a Beat Childhood Cancer Research Consortium trialGiselle L Saulnier Sholler, Genevieve Bergendahl, Elizabeth C Lewis, et al.
Pageof 4